Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesWeighing costs, benefits of HIV treatments
EurekAlert, 09/16/09
Palumbo is co–leading a clinical study of anti–HIV medicines in Africa and India for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group. The randomized trial found that a cohort of 82 HIV–infected children ages 6 to 35 months responded better to treatment with the protease–inhibiting drug lopinavir than did a cohort of 82 children in the same age group who received the anti–retroviral drug nevirapine. The infants all had previously received a single dose of NVP in liquid form at birth, and their mothers each had taken NVP in the form of a single pill during labor in an attempt to prevent HIV transmission.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Should flowers be banned in hospitals?
ScienceDaily, 12/18/09
Breakthrough May Pave the Way for Therapeutic Vaccines
ScienceDaily, 12/18/09
Negative emotions outweigh intent to exercise at health clubs
ScienceDaily, 12/18/09
Article Search
Sponsor